Terms: = Sarcomas AND FGFR3, CD333, 2261, ENSG00000068078, P22607, JTK4, ACH, HSFGFR3EX, CEK2 AND Treatment
8 results:
1. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
2. Managing patients with advanced soft tissue sarcoma: Evolving landscape from an Australian perspective.
Bae S; Brnabic A; Crowe P; Carey-Smith R; Andelkovic V; Singhal N; Stalley P; Yip D; Desai J
Asia Pac J Clin Oncol; 2022 Dec; 18(6):605-613. PubMed ID: 35098667
[TBL] [Abstract] [Full Text] [Related]
3. Clinical characteristics and successful treatment outcomes of children and adolescents with Kaposi sarcoma in Southwestern Tanzania.
Campbell LR; El-Mallawany NK; Slone JS; Malingoti BM; Mehta PS; Scheurer ME; Bacha JM; Peckham-Gregory EC
Pediatr Hematol Oncol; 2022 Feb; 39(1):28-47. PubMed ID: 34243680
[TBL] [Abstract] [Full Text] [Related]
4. Analyses of fgfr3 and PIK3CA mutations in neuroblastomas and the effects of the corresponding inhibitors on neuroblastoma cell lines.
Kostopoulou ON; Holzhauser S; Lange BKA; Ohmayer A; Andonova T; Bersani C; Wickström M; Dalianis T
Int J Oncol; 2019 Dec; 55(6):1372-1384. PubMed ID: 31638167
[TBL] [Abstract] [Full Text] [Related]
5. Establishment of a novel cellular model for myxofibrosarcoma heterogeneity.
Lohberger B; Stuendl N; Leithner A; Rinner B; Sauer S; Kashofer K; Liegl-Atzwanger B
Sci Rep; 2017 Mar; 7():44700. PubMed ID: 28304377
[TBL] [Abstract] [Full Text] [Related]
6. Clinical impact of extensive molecular profiling in advanced cancer patients.
Cousin S; Grellety T; Toulmonde M; Auzanneau C; Khalifa E; Laizet Y; Tran K; Le Moulec S; Floquet A; Garbay D; Robert J; Hostein I; Soubeyran I; Italiano A
J Hematol Oncol; 2017 Feb; 10(1):45. PubMed ID: 28179005
[TBL] [Abstract] [Full Text] [Related]
7. C1q/TNF-related protein-3 exerts the chondroprotective effects in IL-1β-treated SW1353 cells by regulating the FGFR1 signaling.
Huang Y; Wan G; Tao J
Biomed Pharmacother; 2017 Jan; 85():41-46. PubMed ID: 27930985
[TBL] [Abstract] [Full Text] [Related]
8. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets.
van Oosterwijk JG; Meijer D; van Ruler MA; van den Akker BE; Oosting J; Krenács T; Picci P; Flanagan AM; Liegl-Atzwanger B; Leithner A; Athanasou N; Daugaard S; Hogendoorn PC; Bovée JV
Am J Pathol; 2013 Apr; 182(4):1347-56. PubMed ID: 23415961
[TBL] [Abstract] [Full Text] [Related]
